Company Sanofi

SAN

FR0000120578

Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 16:55:00 09/07/2025 BST			After hours 20:28:42
83.32 ^EUR	-0.01%		83.48	+0.19%

07-08	SANOFI : UBS maintains a Buy rating	ZD
07-03	SANOFI : Goldman Sachs reiterates its Neutral rating	ZD

Business description: Sanofi

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows:

- pharmaceutical products (79.8%): prescription drugs in the areas of specialty medicine (63.2% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (36.8%; mainly for the treatment of diabetes and cardiovascular diseases);

- human vaccines (20.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas.

At the end of 2024, the group had 52 production sites worldwide.

In October 2024, the consumer healthcare products business (Opella) was classified as a discontinued operation.

Net sales are distributed geographically as follows: France (4.4%), Europe (17.6%), the United States (48.7%), China (6.5%) and other (22.8%).

Number of employees: 82,878

Sales by Activity: Sanofi

Fiscal Period: December	2020	2021	2022	2023	2024
Biopharma	-	-	-	41.21B	43.95B
Consumer Healthcare	4.45B	4.52B	5.14B	5.23B	-
Pharmaceuticals Excl. Consumer Healthcare	25.8B	27.23B	31.34B	-	-
Vaccines	7.11B	7.42B	8.9B	-	-
Others	-	-	7M	-	339M

See all business segments

Geographical breakdown of sales: Sanofi

Fiscal Period: December	2020	2021	2022	2023	2024
United States	13.46B	14.38B	18.28B	18.51B	19.99B
Rest of The World	7.76B	7.85B	8.39B	13.46B	12.07B
Europe (Excluding France)	-	-	-	8.01B	7.21B
France	-	-	-	2.38B	1.81B
Europe (Excl. Russia)	9.15B	9.76B	10B	-	-
China	2.45B	2.72B	3.12B	-	-
Russia	641M	575M	674M	-	-
Brazil	836M	815M	927M	-	-
North America (Excluding United States)	-	-	-	704M	-
Japan	1.74B	1.66B	1.61B	-	-

See all geographic segments

Executive Committee: Sanofi

Manager	Title	Age	Since
Paul Hudson CEO	Chief Executive Officer	57	31/08/2019
François-Xavier Roger DFI	Director of Finance/CFO	63	31/03/2024
Madeleine Roach COO	Chief Operating Officer	41	30/09/2023
Houman Ashrafian CTO	Chief Tech/Sci/R&D Officer	50	10/09/2023
Thomas Kudsk Larsen IRC	Investor Relations Contact	51	-

See SANOFI governance

Composition of the Board of Directors: Sanofi

Director	Title	Age	Since
Fabienne Lecorvaisier BRD	Director/Board Member	62	02/05/2013
Patrick Kron BRD	Director/Board Member	71	30/04/2014
Christophe Babule BRD	Director/Board Member	59	29/04/2019
Paul Hudson BRD	Director/Board Member	57	29/10/2019
Rachel Duan BRD	Director/Board Member	55	27/04/2020
Lise Kingo BRD	Director/Board Member	63	27/04/2020
Barbara Lavernos BRD	Director/Board Member	57	29/04/2021
Yann Tran BRD	Director/Board Member	59	30/04/2021
Wolfgang Laux BRD	Director/Board Member	57	31/03/2021
Carole Ferrand BRD	Director/Board Member	54	02/05/2022

Composition of the Board of Directors

Shareholders: Sanofi

Name	Equities	%	Valuation
L'ORÉAL 7.188 %	88,670,657	7.188 %	8 557 M €
Dodge & Cox 1.825 %	22,512,304	1.825 %	2 172 M €
SANOFI 1.317 %	16,245,648	1.317 %	1 568 M €
Amundi Asset Management SASU (Investment Management) 0.4503 %	5,554,878	0.4503 %	536 M €
OFI Invest Asset Management SA 0.3048 %	3,760,272	0.3048 %	363 M €

Name	Equities	%	Valuation
Dodge & Cox 2.897 %	73,193,057	2.897 %	3 536 M €
Fisher Asset Management LLC 0.537 %	13,566,329	0.537 %	655 M €
Invesco Advisers, Inc. 0.4695 %	11,859,545	0.4695 %	573 M €
T. Rowe Price International Ltd. 0.4369 %	11,036,878	0.4369 %	533 M €
Merrill Lynch International 0.412 %	10,407,790	0.412 %	503 M €

List of SANOFI shareholders

Holdings: Sanofi

Name	Equities	%	Valuation
SANOFI 1.32%	16,245,648	1.32%	1,567,740,935 $
SANOFI INDIA LIMITED 60.4%	13,909,587	60.4%	1,034,112,001 $
SANOFI INDIA LIMITED 60.4%	13,909,587	60.4%	923,724,128 $
EUROAPI 29.6%	28,298,074	29.6%	95,866,234 $
MEIRAGTX HOLDINGS PLC 15.61%	12,197,737	15.61%	79,529,245 $
NOVAVAX, INC. 4.3%	6,880,481	4.3%	43,347,030 $
ANAPTYSBIO, INC. 2.7%	821,917	2.7%	18,246,557 $
ANAPTYSBIO, INC. 8%	1,157,926	8%	16,523,604 $
INNATE PHARMA 9.96%	8,345,387	9.96%	14,909,868 $
VICORE PHARMA HOLDING AB 6.21%	14,571,428	6.21%	11,635,285 $

Company details: Sanofi

Sanofi

46, avenue de la Grande Armée

75017, Paris

+33 1 53 77 40 00

http://www.sanofi.com

Group companies: Sanofi

Name	Category and Sector
Helvepharm AG Helvepharm AG Pharmaceuticals: MajorHealth Technology Part of Sanofi, Helvepharm AG is a Swiss company that manufactures generic drugs. The company is based in Frauenfeld, Switzerland. Helvepharm was acquired by Sanofi from DocMorris Ltd. on July 28, 2009.	Pharmaceuticals: Major
Sanofi-Aventis Holdings (Ireland) Ltd. Sanofi-Aventis Holdings (Ireland) Ltd. MiscellaneousMiscellaneous Sanofi-Aventis Holdings (Ireland) Ltd., a subsidiary of Sanofi, is an Irish company. The firm functions as an investment holding company.	Miscellaneous
Sanofi Srl Sanofi Srl Pharmaceuticals: MajorHealth Technology Sanofi SpA engages in the research, production, and distribution of pharmaceuticals. It provides solutions for the treatment of diseases in various medical fields such as cardiovascular, diabetes, oncology and blood cancers, nephrology, equivalent medicines, rare diseases, and multiple sclerosis as well as develops vaccines. The company was founded in 1973 and is headquartered in Milan, Italy.	Pharmaceuticals: Major
Sanofi Belgium NV Sanofi Belgium NV BiotechnologyHealth Technology Part of Sanofi, Sanofi Belgium NV is a Belgian company that produces and markets biological drugs. The company is based in Diegem, Belgium. The company was founded in 1998. The CEO is Johan Heylen.	Biotechnology
Rhone-Poulenc Rorer Asia Pacific Ltd.

See all subsidiaries

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
SANOFI	-0.01%	-0.35%	-9.46%	-16.80%	119B
ELI LILLY AND COMPANY	+1.29%	+0.74%	-15.81%	+137.14%	698B
JOHNSON & JOHNSON	+0.02%	+0.02%	+5.81%	-12.76%	375B
ABBVIE INC.	+0.37%	-0.25%	+13.22%	+24.17%	335B
NOVO NORDISK A/S	-1.53%	+0.35%	-54.14%	+9.26%	313B
ROCHE HOLDING AG	+0.89%	-0.04%	+6.30%	-20.36%	259B
NOVARTIS AG	-0.16%	-0.89%	+0.47%	+17.53%	240B
ASTRAZENECA PLC	+0.21%	-0.27%	-13.25%	-7.10%	217B
MERCK & CO., INC.	+3.18%	+1.60%	-33.58%	-11.23%	204B
AMGEN INC.	+0.01%	-0.13%	-6.16%	+19.64%	160B
Average	+0.39%	+0.54%	-10.66%	+13.95%	292.12B
Weighted average by Cap.	+0.45%	+0.40%	-10.78%	+33.61%